Cui X - Search Results

1

The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance.

Casa AJ, Dearth RK, Litzenburger BC, Lee AV, Cui X. Casa AJ, et al. Among authors: cui x. Front Biosci. 2008 May 1;13:3273-87. doi: 10.2741/2925. Front Biosci. 2008. PMID: 18508432 Review.

2

Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.

Lee AV, Cui X, Oesterreich S. Lee AV, et al. Among authors: cui x. Clin Cancer Res. 2001 Dec;7(12 Suppl):4429s-4435s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916236 Review.

3

New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.

Lee AV, Schiff R, Cui X, Sachdev D, Yee D, Gilmore AP, Streuli CH, Oesterreich S, Hadsell DL. Lee AV, et al. Among authors: cui x. Clin Cancer Res. 2003 Jan;9(1 Pt 2):516S-23S. Clin Cancer Res. 2003. PMID: 12538509 Review.

4

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV. Cui X, et al. Mol Endocrinol. 2003 Apr;17(4):575-88. doi: 10.1210/me.2002-0318. Epub 2003 Jan 2. Mol Endocrinol. 2003. PMID: 12554765

5

Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.

Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV. Oesterreich S, et al. Among authors: cui x. Cancer Res. 2003 Sep 1;63(17):5203-8. Cancer Res. 2003. PMID: 14500345

6

Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.

Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV. Cui X, et al. Oncogene. 2003 Oct 9;22(44):6937-41. doi: 10.1038/sj.onc.1206803. Oncogene. 2003. PMID: 14534541

7

Regulatory nodes that integrate and coordinate signaling as potential targets for breast cancer therapy.

Cui X, Lee AV. Cui X, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):396S-401S. doi: 10.1158/1078-0432.ccr-031205. Clin Cancer Res. 2004. PMID: 14734498

8

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. Cui X, et al. J Clin Oncol. 2005 Oct 20;23(30):7721-35. doi: 10.1200/JCO.2005.09.004. J Clin Oncol. 2005. PMID: 16234531 Review.

9

Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.

Kim HJ, Cui X, Hilsenbeck SG, Lee AV. Kim HJ, et al. Among authors: cui x. Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1013s-1018s. doi: 10.1158/1078-0432.CCR-05-2128. Clin Cancer Res. 2006. PMID: 16467118

10

Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.

Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV. Cui X, et al. Cancer Res. 2006 May 15;66(10):5304-13. doi: 10.1158/0008-5472.CAN-05-2858. Cancer Res. 2006. PMID: 16707456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,665 results

Search Page

Filters